These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31173126)

  • 1. Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis.
    Mankia K; Cheng Z; Do T; Hunt L; Meade J; Kang J; Clerehugh V; Speirs A; Tugnait A; Hensor EMA; Nam JL; Devine DA; Emery P
    JAMA Netw Open; 2019 Jun; 2(6):e195394. PubMed ID: 31173126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is periodontitis a prognostic factor in order to indicate antibodies against citrullinated peptides in patients with rheumatoid arthritis?
    Reichert S; Jurianz E; Natalie P; Schlumberger W; Dähnrich C; Johannsen N; Altermann W; Schlaf G; Keyßer G; Schaefer C; Schaller HG; Schulz S
    Clin Exp Rheumatol; 2020; 38(2):227-238. PubMed ID: 31287408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
    Mikuls TR; Payne JB; Yu F; Thiele GM; Reynolds RJ; Cannon GW; Markt J; McGowan D; Kerr GS; Redman RS; Reimold A; Griffiths G; Beatty M; Gonzalez SM; Bergman DA; Hamilton BC; Erickson AR; Sokolove J; Robinson WH; Walker C; Chandad F; O'Dell JR
    Arthritis Rheumatol; 2014 May; 66(5):1090-100. PubMed ID: 24782175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients.
    Wan Jiun T; Taib H; Majdiah Wan Mohamad W; Mohamad S; Syamimee Wan Ghazali W
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110940. PubMed ID: 37722261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis.
    Cheng Z; Do T; Mankia K; Meade J; Hunt L; Clerehugh V; Speirs A; Tugnait A; Emery P; Devine D
    Ann Rheum Dis; 2021 Feb; 80(2):162-168. PubMed ID: 33004333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population.
    Äyräväinen L; Leirisalo-Repo M; Kuuliala A; Ahola K; Koivuniemi R; Meurman JH; Heikkinen AM
    BMJ Open; 2017 Jan; 7(1):e011916. PubMed ID: 28143836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres.
    Lappin DF; Apatzidou D; Quirke AM; Oliver-Bell J; Butcher JP; Kinane DF; Riggio MP; Venables P; McInnes IB; Culshaw S
    J Clin Periodontol; 2013 Oct; 40(10):907-15. PubMed ID: 23902301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study.
    Reichert S; Schlumberger W; Dähnrich C; Hornig N; Altermann W; Schaller HG; Schulz S
    J Transl Med; 2015 Aug; 13():283. PubMed ID: 26319714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults.
    Okada M; Kobayashi T; Ito S; Yokoyama T; Komatsu Y; Abe A; Murasawa A; Yoshie H
    J Periodontol; 2011 Oct; 82(10):1433-41. PubMed ID: 21342003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.
    Mikuls TR; Thiele GM; Deane KD; Payne JB; O'Dell JR; Yu F; Sayles H; Weisman MH; Gregersen PK; Buckner JH; Keating RM; Derber LA; Robinson WH; Holers VM; Norris JM
    Arthritis Rheum; 2012 Nov; 64(11):3522-30. PubMed ID: 22736291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
    Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.
    Arvikar SL; Collier DS; Fisher MC; Unizony S; Cohen GL; McHugh G; Kawai T; Strle K; Steere AC
    Arthritis Res Ther; 2013; 15(5):R109. PubMed ID: 24017968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients.
    Ceccarelli F; Orrù G; Pilloni A; Bartosiewicz I; Perricone C; Martino E; Lucchetti R; Fais S; Vomero M; Olivieri M; di Franco M; Priori R; Riccieri V; Scrivo R; Shoenfeld Y; Alessandri C; Conti F; Polimeni A; Valesini G
    Clin Exp Immunol; 2018 Nov; 194(2):244-252. PubMed ID: 30009382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
    Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
    Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
    Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
    J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Sectional Evaluation of Periodontal Status and Microbiologic and Rheumatoid Parameters in a Large Cohort of Patients With Rheumatoid Arthritis.
    Schmickler J; Rupprecht A; Patschan S; Patschan D; Müller GA; Haak R; Mausberg RF; Schmalz G; Kottmann T; Ziebolz D
    J Periodontol; 2017 Apr; 88(4):368-379. PubMed ID: 27858553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study.
    Bello-Gualtero JM; Lafaurie GI; Hoyos LX; Castillo DM; De-Avila J; Munevar JC; Unriza S; Londoño J; Valle-Oñate R; Romero-Sánchez C
    J Periodontol; 2016 Apr; 87(4):346-56. PubMed ID: 26609697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study.
    de Smit M; Westra J; Vissink A; Doornbos-van der Meer B; Brouwer E; van Winkelhoff AJ
    Arthritis Res Ther; 2012 Oct; 14(5):R222. PubMed ID: 23075462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
    Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
    Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.
    Mikuls TR; Payne JB; Reinhardt RA; Thiele GM; Maziarz E; Cannella AC; Holers VM; Kuhn KA; O'Dell JR
    Int Immunopharmacol; 2009 Jan; 9(1):38-42. PubMed ID: 18848647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.